3623 results for «2638»

Filter By

3623 results

Hotlines and innovations on stable CAD - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of stable CAD:

  • ANGIE trial
  • Prevention of AKI with sodium bicarbonate
  • AI-based plaque characterisation
Hotlines and innovations on stable CAD - PCR e-Course 2020

Hotlines and innovations on bifurcation lesions - PCR e-Course 2020

View this hot line from PCR e-Course 2020 on the topic of bifurcation stenting regarding the role of deployment technique in a global registry.

Hotlines and innovations on bifurcation lesions - PCR e-Course 2020

Innovative solutions to treat diabetic patients

Watch this video if you want to understand the need of dedicated DES for Diabetes Mellitus (DM) patients, to understand and learn the differences of CAD for diabetic compared to non-diabetic patients, to see clinical evidences and results for the treatment of Diabetic patients with DES+...

Innovative solutions to treat diabetic patients

Hotlines and innovations on other coronary interventions - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of other coronary interventions:

  • Gender differences in outcomes after rational atherectomy PCI
  • Intensified antiplatelet therapy in post-PCI patients with HOPR
Hotlines and innovations on other coronary interventions - PCR e-Course 2020

TAVI: Full one-year Evolut low-risk randomised results and economic implications

EVOLUT Low Risk Trial of self-expanding TAVI versus SAVR: discover the key take-aways from the economic analysis as well as the health economics implications  to understand the potential drivers for TAVI cost-effectives in Europe.

Videos included on this page: the Hot Line presentation and an Investigator Perspective.

Full one-year Evolut low-risk randomised results and economic implications

TAVI for bicuspid valves with Evolut: BIVOLUT-X registry

Learn more about transcatheter treatment of bicuspid aortic valves with the EVOLUT platform, the BIVOLUT-X registry design, and key outcomes and practical implications of the study.

Videos included on this page: the Hot Line presentation and an Investigator Perspective.

New evidence in treating bicuspid TAVI patients

Hotlines and innovations on valve interventions - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of valve interventions:

  • Safety and efficacy of the TaurusOne TAVR system for aortic stenosis
  • Quantitative angiographic assessment of MR after mitral procedures
Hotlines and innovations on valve interventions - PCR e-Course 2020

Aspirin vs. P2Y12 monotherapy in Onyx-1

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to review the highlights of the Onyx ONE Month DAPT Program and to listen to commentary on the SAPT late breaker sub-analysis comparing the safety and efficacy of administering aspirin vs. P2Y12 inhibitor.

Videos included on this page: the Hot Line...

Aspirin vs. P2Y12 monotherapy in Onyx-1

SYNERGY MEGATRON - Transforming your left main bifurcation strategy for improved outcomes

Watch this session if you want to review steps for PCI in complex left main bifurcation lesions, to advance your knowledge on IVUS-guided PCI in left main disease and to learn about a purpose-built new stent platform for large vessels and left main.

SYNERGY MEGATRON - Transforming your left main bifurcation strategy for improved outcomes

Mastering complex calcified aortic stenosis

Watch this session if you want to advance your knowledge in imaging assessment of complex calcified aortic stenosis and to learn about device selection and implantation technique in calcified anatomies.

Mastering complex calcified aortic stenosis

Update on the regulation of high-risk medical devices: a transatlantic perspective

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to get an update on new developments in the regulation of high-risk medical devices in Europe and the USA and to learn about opportunities for physicians to become more involved in the regulatory environment.

This session was originally presented during PCR...

Update on the regulation of high-risk medical devices

Clip technology you know and trust, designed for the tricuspid valve

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to learn why diagnosis and treatment of tricuspid regurgitation is the next transcatheter valvular treatment frontier and to learn more about TriClip, dedicated therapy option for patients suffering from tricuspid regurgitation.

Clip technology you know and trust, designed for the tricuspid valve

Tailoring mitral repair: new evidence demonstrating improved patient outcomes

27 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to tailor the mitral valve repair and optimise treatment based on etiology and mitral valve anatomy and to learn about current MitraClip clip options as well as look into the future of the mitral repair treatment.

Tailoring mitral repair: new evidence demonstrating improved patient outcomes

Coronary Microvascular Dysfunction: Why diagnosis in the Cathlab does matter

26 Jun 2020 – From PCR e-Course 2020

Watch this session to learn more about the prevalence of coronary microvascular dysfunction & angina, and to learn why diagnosis of coronary microvascular dysfunction is so important.

Coronary Microvascular Dysfunction

Selection of appropriate devices for retrograde CTO cases

25 Jun 2020 – From PCR e-Course 2020

Watch this roundtable discussion if you want to witness appropriate device selection for retrograde approach, to improve your skills as a CTO operator and to have interactive discussions about available chronic total occlusion wires and devices.

Selection of appropriate devices for retrograde CTO cases

To stent or not to stent? Discussion of complex PCI cases

26 Jun 2020 – From PCR e-Course 2020

Watch this roundtable discussion if you want to join a detailed discussion about the drug-eluting stent vs. drug-coated balloon approach, to discuss the importance of lesion preparation for optimal coronary intervention results and to share insights about state-of-the-art treatment options from leading expert.

To stent or not to stent? Discussion of complex PCI cases

Current evidence for the interventional treatment of INOCA patients

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to understand how Reducer therapy can help the interventionalist safely improve symptoms of his "end stage" patient, to recognize that microvascular disease is common and has poor prognosis and to understand how Reducer therapy can address patients with microvascular disease.

Current evidence for the interventional treatment of INOCA patients

Ultra low contrast: new skills and technologies for next frontier in PCI

27 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to learn why ULCPCI will be needed for patients who have developed cardiomyopathy due wait linked to COVID outbreak, to understand what tools we have in the cathlab to perform ULCPCI and to learn how to practice ultra-low contrast in...

Ultra low contrast: new skills and technologies for next frontier in PCI

Best real-world applications of Shockwave intravascular lithotripsy (IVL) in coronary calcium

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to understand how intravascular lithotripsy works through real-world cases, to hear from global leading physicians about where intravascular lithotripsy fits into their clinical practice and to hear about some of the most prominent cases of coronary intravascular lithotripsy.

Best real-world applications of Shockwave intravascular lithotripsy (IVL) in coronary calcium

Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target...

Target all comers outcomes update
Didn’t find what you were looking for?